Postmastectomy radiation therapy for lymph node-negative, locally advanced breast cancer after modified radical mastectomy: Analysis of the NCI Surveillance, Epidemiology, and End Results database

Cancer

Volumn 113, Issue 1, 2008, Pages 38-47

  Yu, James B ^a   Wilson, Lynn D ^a   Dasgupta, Tina ^a   Castrucci, William A ^a   Weidhaas, Joanne B ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Postmastectomy radiation; Postoperative radiation; SEER; T3N0

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; LYMPH NODE; MAJOR CLINICAL STUDY; MASTECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SCORING SYSTEM; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; SEER PROGRAM; SURVIVAL ANALYSIS;

EID: 47149106876     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23512     Document Type: Article

References (17)

1. Helinto M, Blomqvist C, Heikkila P, et al. Post-mastectomy radiotherapy in pT3N0M0 breast cancer: is it needed? Radiother Oncol. 1999;52:213-217.
2. Overgaard M, Hansen PR, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 1997;337:949-955.
3. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomized trial. Lancet. 1999;353:1641-1648.
4. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet. 2005; 366:2087-2106.
5. Jagsi R, Raad RA, Goldberg S, et al. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys. 2005;62:1035-1039.
6. Floyd SR, Buchholz TA, Haffty BG, et al. Low local recurrence rate without postmastectomy radiation in node-negative breast cancer with tumors 5 cm and larger. Int J Radiat Oncol Biol Phys. 2006;66:358-364.
7. Taghian AG, Jeong JH, Manmouas ER et al. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol. 2006;24:3927-3932.
8. Carlson RW, Anderson BO, Burstein HJ, et al. NCCN breast cancer clinical practice guidelines in oncology. Version 1, 2007. Available at http://www.nccn.org/professionals/physician_gls/ PDF/breast.pdf Accessed September 8, 2007.
9. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
10. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127:757-763.
11. Smith BD, Smith GL, Haffty BG. Postmastectomy radiation and mortality in women with T1-2 node-positive breast cancer. J Clin Oncol. 2005;23:1409-1419.
12. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Limited-Use Data (1973-2004), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission.
13. Fritz A, Percy C, Jack A, Sobin LH, Parkin MD (eds.). International Classification of Diseases for Oncology (ed. 3). Geneva: World Health Organization; 2000.
14. Leuven E, Sianesi B. "PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing." 2003. Available at: http://ideas.repec.org/c/ boc/bocode/s432001. html Version 3.0.0. Accessed September 12, 2007.
15. Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39:33-38
16. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295:2492-502.
17. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365: 1687-1717.